• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

磷酸二酯和硫代磷酸酯小干扰RNA的生物分布

Biodistribution of phosphodiester and phosphorothioate siRNA.

作者信息

Braasch Dwaine A, Paroo Zain, Constantinescu Anca, Ren Gang, Oz Orhan K, Mason Ralph P, Corey David R

机构信息

Departments of Pharmacology and Biochemistry, University of Texas Southwestern Medical Center, Dallas, TX 75390-9041, USA.

出版信息

Bioorg Med Chem Lett. 2004 Mar 8;14(5):1139-43. doi: 10.1016/j.bmcl.2003.12.074.

DOI:10.1016/j.bmcl.2003.12.074
PMID:14980652
Abstract

Short interfering RNAs (siRNAs) are valuable tools for analyzing protein function in mammalian cell culture. This success has led to high expectations for in vivo and therapeutic applications. However, the pharmacokinetic properties of siRNA are not known. Here we report the biodistribution of a phosphodiester (PO) siRNA duplex and examine the effect of phosphorothioate (PS) linkages. Our findings indicate that biodistribution of siRNA is similar to that for single-stranded antisense oligonucleotides and offer insights for use of siRNA in vivo.

摘要

小干扰RNA(siRNA)是分析哺乳动物细胞培养中蛋白质功能的宝贵工具。这一成功使得人们对其体内和治疗应用寄予厚望。然而,siRNA的药代动力学特性尚不清楚。在此,我们报告了一种磷酸二酯(PO)siRNA双链体的生物分布,并研究了硫代磷酸酯(PS)连接的作用。我们的研究结果表明,siRNA的生物分布与单链反义寡核苷酸相似,并为siRNA在体内的应用提供了见解。

相似文献

1
Biodistribution of phosphodiester and phosphorothioate siRNA.磷酸二酯和硫代磷酸酯小干扰RNA的生物分布
Bioorg Med Chem Lett. 2004 Mar 8;14(5):1139-43. doi: 10.1016/j.bmcl.2003.12.074.
2
Chirality matters: stereo-defined phosphorothioate linkages at the termini of small interfering RNAs improve pharmacology in vivo.手性很重要:小干扰 RNA 末端的立体定义的硫代磷酸酯键可改善体内的药理学性质。
Nucleic Acids Res. 2022 Feb 22;50(3):1221-1240. doi: 10.1093/nar/gkab544.
3
Pharmacokinetic Profiling of Conjugated Therapeutic Oligonucleotides: A High-Throughput Method Based Upon Serial Blood Microsampling Coupled to Peptide Nucleic Acid Hybridization Assay.共轭治疗性寡核苷酸的药代动力学分析:一种基于串联血微采样与肽核酸杂交分析的高通量方法。
Nucleic Acid Ther. 2017 Dec;27(6):323-334. doi: 10.1089/nat.2017.0690. Epub 2017 Oct 12.
4
In vivo pharmacokinetics, tissue distribution and underlying mechanisms of various PEI(-PEG)/siRNA complexes.各种聚乙烯亚胺(-聚乙二醇)/小干扰RNA复合物的体内药代动力学、组织分布及潜在机制
Toxicol Appl Pharmacol. 2009 Apr 1;236(1):97-108. doi: 10.1016/j.taap.2009.01.014. Epub 2009 Jan 29.
5
Uptake, efficacy, and systemic distribution of naked, inhaled short interfering RNA (siRNA) and locked nucleic acid (LNA) antisense.吸入型裸露短干扰 RNA(siRNA)和锁核酸(LNA)反义寡核苷酸的摄取、疗效和系统分布。
Mol Ther. 2011 Dec;19(12):2163-8. doi: 10.1038/mt.2011.206. Epub 2011 Oct 4.
6
Biodistribution and metabolism of internally 3H-labeled oligonucleotides. I. Comparison of a phosphodiester and a phosphorothioate.体内3H标记寡核苷酸的生物分布与代谢。I. 磷酸二酯和硫代磷酸酯的比较。
Mol Pharmacol. 1994 May;45(5):932-43.
7
Central administration of small interfering RNAs in rats: a comparison with antisense oligonucleotides.大鼠体内小干扰RNA的中枢给药:与反义寡核苷酸的比较。
Eur J Pharmacol. 2005 Oct 17;522(1-3):30-7. doi: 10.1016/j.ejphar.2005.08.021. Epub 2005 Oct 6.
8
Biodistribution of 68Ga-labelled phosphodiester, phosphorothioate, and 2'-O-methyl phosphodiester oligonucleotides in normal rats.68Ga标记的磷酸二酯、硫代磷酸酯和2'-O-甲基磷酸二酯寡核苷酸在正常大鼠体内的生物分布。
Eur J Pharm Sci. 2005 Sep;26(1):26-38. doi: 10.1016/j.ejps.2005.04.017.
9
Challenges for RNAi in vivo.RNA干扰在体内面临的挑战。
Trends Biotechnol. 2004 Aug;22(8):390-4. doi: 10.1016/j.tibtech.2004.06.004.
10
Biodistribution and metabolism of internally 3H-labeled oligonucleotides. II. 3',5'-blocked oligonucleotides.体内3H标记寡核苷酸的生物分布与代谢。II. 3',5'-封闭寡核苷酸。
Mol Pharmacol. 1995 Mar;47(3):636-46.

引用本文的文献

1
Advances and prospects of RNA delivery nanoplatforms for cancer therapy.用于癌症治疗的RNA递送纳米平台的进展与展望
Acta Pharm Sin B. 2025 Jan;15(1):52-96. doi: 10.1016/j.apsb.2024.09.009. Epub 2024 Sep 14.
2
Principle, application and challenges of development siRNA-based therapeutics against bacterial and viral infections: a comprehensive review.基于小干扰RNA的抗细菌和病毒感染疗法的原理、应用及发展挑战:综述
Front Microbiol. 2024 Jun 13;15:1393646. doi: 10.3389/fmicb.2024.1393646. eCollection 2024.
3
ApoE-functionalization of nanoparticles for targeted brain delivery-a feasible method for polyplexes?
载脂蛋白 E 功能化纳米颗粒用于靶向脑递送——多聚物载体的一种可行方法?
Drug Deliv Transl Res. 2024 Jun;14(6):1660-1677. doi: 10.1007/s13346-023-01482-w. Epub 2023 Dec 12.
4
Emerging delivery approaches for targeted pulmonary fibrosis treatment.靶向肺纤维化治疗的新兴给药途径。
Adv Drug Deliv Rev. 2024 Jan;204:115147. doi: 10.1016/j.addr.2023.115147. Epub 2023 Dec 6.
5
Using RNA-based therapies to target the kidney in cardiovascular disease.利用基于RNA的疗法靶向治疗心血管疾病中的肾脏。
Front Cardiovasc Med. 2023 Oct 6;10:1250073. doi: 10.3389/fcvm.2023.1250073. eCollection 2023.
6
Imaging of [60]Fullerene-Based Molecular Spherical Nucleic Acids by Positron Emission Tomography.正电子发射断层扫描术对[60]富勒烯基分子球形核酸的成像。
Mol Pharm. 2023 Oct 2;20(10):5043-5051. doi: 10.1021/acs.molpharmaceut.3c00370. Epub 2023 Aug 2.
7
Oral Delivery of Nucleic Acid Therapies for Local and Systemic Action.口服递呈核酸治疗药物以实现局部和全身作用
Pharm Res. 2023 Jan;40(1):107-122. doi: 10.1007/s11095-022-03415-7. Epub 2022 Oct 21.
8
Nanoparticles-Based Strategies to Improve the Delivery of Therapeutic Small Interfering RNA in Precision Oncology.基于纳米颗粒的策略改善治疗性小干扰RNA在精准肿瘤学中的递送
Pharmaceutics. 2022 Jul 29;14(8):1586. doi: 10.3390/pharmaceutics14081586.
9
Nucleic Acid Drugs-Current Status, Issues, and Expectations for Exosomes.核酸药物——外泌体的现状、问题与展望
Cancers (Basel). 2021 Oct 5;13(19):5002. doi: 10.3390/cancers13195002.
10
MicroRNAs Regulating Autophagy in Neurodegeneration.微小 RNA 在神经退行性变中的自噬调控。
Adv Exp Med Biol. 2021;1208:191-264. doi: 10.1007/978-981-16-2830-6_11.